ENDOMETRIAL RECEPTIVITY
12
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
17%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters
Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation Failure
Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
The Clinical Efficiency of Tb-ERA in Chinese RIF Patients
Endometrial Markers in Autoimmune Diseases
Modification of Endometrial Receptivity After Vaginal Seminal Plasma Application
Microbiome and Endometrial Receptivity in Obese Infertile Women
Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium
Comparison of Blood Flow in the Arteriae Uterinae in Ovarian Stimulation Cycles
Serum and Uterine Progesterone Levels and ERA Test.
The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation